[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:22q11-2-deletion-syndrome":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":48,"states":49},"22q11.2 Deletion Syndrome",6,4,[8,16,22,28,34,41],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07284641","Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)",[12],"Phase 2","RECRUITING","2026-08-26T02:17:02.694423Z","2026-05-05T02:43:28.474885Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT00556530","Examining Genetic Factors That Affect the Severity of 22q11.2 Deletion Syndrome",[],"2026-08-26T02:16:10.529598Z","2026-05-13T02:55:06.039685Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":26,"content_modified":27},"NCT07643896","The ADVANCE (Assay Development and Validation for Pre-Natal and Obstetric Conditions) Study is the Largest U.S.-Based Prospective Study Demonstrating a Circulating Fetal Cell (CFC) Based Approach to Non-invasive Fetal Risk Assessment",[],"2026-08-26T02:18:18.766496Z","2026-06-14T18:39:22.266078Z",{"nct_id":29,"title":30,"phases":31,"status":13,"updated_at":32,"content_modified":33},"NCT07493096","Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disorders",[],"2026-08-26T02:18:23.582895Z","2026-05-13T02:55:06.711327Z",{"nct_id":35,"title":36,"phases":37,"status":38,"updated_at":39,"content_modified":40},"NCT03836300","Parent and Infant Inter(X)Action Intervention (PIXI)",[],"ENROLLING_BY_INVITATION","2026-08-26T02:18:48.678868Z","2026-06-16T05:54:07.971455Z",{"nct_id":42,"title":43,"phases":44,"status":38,"updated_at":46,"content_modified":47},"NCT01852370","Sequential Cadaveric Lung and Bone Marrow Transplant for Immune Deficiency Diseases",[45],"Phase 1\u002FPhase 2","2026-08-26T02:17:44.240289Z","2026-06-16T05:54:07.951235Z",[],[]]